|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02563 BIOSTAR PHARM-B
Nominal 
26.350 +0.250 (+0.958%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 |
| Property, plant, equip. & others | 122,710 | 19.249% | 102,902 |
| Land & other Lease Assets | 13,477 | -9.319% | 14,862 |
| Intangible Assets | 1,627 | -42.549% | 2,832 |
| Interests in Asso. & JCEs | 0 | -- | 0 |
| Other Non-current Assets | 1,000 | -6.716% | 1,072 |
| 138,814 | 14.092% | 121,668 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | ||
| Inventories | 27,267 | -12.350% | 31,109 | |
| Trade Receivables | 11,159 | -67.767% | 34,620 | |
| Cash & Bank Balances | 38,087 | -36.634% | 60,106 | |
| Other Current Assets | 557,017 | -17.945% | 678,835 | |
| Assets Held for Sale | 0 | -- | 0 | |
| 633,530 | -21.268% | 804,670 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | |||
| Trade Payables | 24,440 | 21.598% | 20,099 | ||
| S-T Debt & Leases | 732 | -32.906% | 1,091 | ||
| Other Current Liabilities | 18,571 | -39.181% | 30,535 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | ||
| 43,743 | -15.432% | 51,725 | |||
| Net Current Assets | 589,787 | -21.669% | 752,945 | ||
| Total Assets Less Current Liabilities | 728,601 | -16.694% | 874,613 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | ||||
| L-T Debt & Leases | 167 | -79.459% | 813 | |||
| Other Non-current Liabilities | 5,273 | -10.247% | 5,875 | |||
| 5,440 | -18.660% | 6,688 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | |||||
| Share Capital | 350,000 | 0.000% | 350,000 | ||||
| Reserves | 373,161 | -27.951% | 517,925 | ||||
| Others | 0 | -- | 0 | ||||
| Shareholders' Funds | 723,161 | -16.679% | 867,925 | ||||
| Non-controlling Interests | 0 | -- | 0 | ||||
| Others | 0 | -- | 0 | ||||
| 723,161 | -16.679% | 867,925 | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | |
| Commitments | 108,402 | -20.434% | 136,242 |
| Contingent Liabilities | 0 | -- | 0 |
| Remarks: | Real time quote last updated: 04/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -189,644,000 |
| %Change | 18.150% |
| EPS / (LPS) | RMB -0.540 |
| NBV Per Share (¥) | RMB -- |